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Background: Fenfluramine-phentermine (fen-phen) is associated with valve disease. This study investigates whether these drugs cause cell 
prolifeartion.
Methods: Fen and phen was tested for proliferation via thymidine assay. Ex vivo surgically removed FenPhen valves (N=10), carcinoid valves (CHD)
(n=26), and normal valves (n=10) were tested for Proliferating Cell Nuclear Antigen (PCNA).
Results: Fen, Phen,Serotonin and Fen-Phen increased proliferation in the cell assay over control. (p<0.05 ) N=20(Fig 2). Proliferation measured 
with PCNA stain in both valve lesions were higher than the normal (p<0.001) (See Table).  
Conclusion: FenPhen have a direct proliferative effect on valve interstitial cells in vitro and ex vivo. This data demonstrates that Fen-Phen causes 
cell proliferation in the heart valve. 
Ex vivo PCNA valve quantification
FenPhen CHD Normal
PCNA cells/mm2 22.8 +/- 4.54.* 34 +/-2.54* 1.26 +/- 0.47
